Obsessive-compulsive disorder (OCD) affects approximately 2-3% of the population and is characterized by persistent unwanted thoughts (obsessions) and repetitive behaviors (compulsions) that can significantly impair quality of life. Standard treatments include SSRIs and cognitive-behavioral therapy with exposure and response prevention, but up to 40% of patients do not achieve adequate relief. Emerging research suggests that ketamine, which works through a different brain mechanism than traditional medications, may offer a new avenue for individuals with treatment-resistant OCD.
A proof-of-concept crossover trial by Rodriguez et al. (2013), published in Neuropsychopharmacology, found that a single intravenous ketamine infusion produced rapid and significant anti-obsessional effects in unmedicated adults with OCD. Over half of the participants met response criteria within one week of ketamine administration. A subsequent study by the same research group (Rodriguez et al., 2016) explored the effects of repeated ketamine infusions and observed that some patients maintained improvement over the treatment course.
While these findings are promising, research on ketamine for OCD remains in its early stages. Studies have generally been small, and the optimal dosing, frequency, and long-term outcomes are still being investigated. Ketamine is not FDA-approved for OCD and is used off-label when prescribed for this condition. For more details, see our article on ketamine and OCD: emerging evidence.
1. Consultation
Schedule a 60-minute telehealth evaluation with a physician experienced in ketamine-assisted therapy. We assess your OCD symptoms, treatment history, and suitability for ketamine.
2. Personalized protocol
If ketamine is appropriate, your physician designs a tailored treatment plan. Medication is prescribed and delivered to your home.
3. Ongoing support
Complete at-home sessions with continued clinical follow-up. Your physician monitors symptom changes and adjusts your protocol as needed.
Preliminary research suggests ketamine may help reduce obsessive-compulsive symptoms, particularly in individuals who have not responded to SSRIs or cognitive-behavioral therapy. However, research is still in early stages, and ketamine is not FDA-approved for OCD.
While SSRIs work primarily on the serotonin system and can take weeks to show effects, ketamine acts on the glutamate system through NMDA receptor modulation. This different mechanism may explain why some patients who do not respond to SSRIs may respond to ketamine, and why effects may appear more rapidly.
No. Ketamine is FDA-approved as an anesthetic and is used off-label for OCD. Its use for OCD is based on emerging clinical evidence, and it should only be prescribed by a licensed physician who can evaluate your specific situation.
The duration of symptom relief varies between individuals. Some studies have reported that a single ketamine dose may reduce OCD symptoms for up to one week, though repeated treatments are typically needed for sustained benefit. Your physician will work with you to determine an appropriate treatment schedule.
Ready to explore ketamine therapy for OCD?
Appointments often available within 24 hours.
Check Appointment Availability